05/18/2024
Last Tuesday's Drug Discovery Biology & Bioinformatics Strategy Meeting in Princeton buzzed with a critical discussion on financing blueprints for your next breakthrough!
VC expert Gunaretnam (Guna) Rajagopal of Samsara BioCapital, expertly guided our high-powered panel: Christopher Conway (Curia), President of Research and Development, Marcie Glicksman (EnClear Therapies), VP Biology, and myself, Nikolaos Tezapsidis (Neurotez, Inc.), President & CEO
From go-to-clinic to go-to-market and go-to-fundraising strategies, the panel dissected the pros and cons of various financing blueprints, offering invaluable insights for attendees.
Missed the session? Stay tuned for more event highlights! hashtag hashtag hashtag hashtag